Seagen Inc Financials

Seagen Stock Summary

Seagen competes with Biomarin Pharmaceutical, Alnylam Pharmaceuticals, Exelixis, Halozyme Therapeutics, and Legend Biotech. Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. Seagen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2675 people.

Seagen Key Financial Ratios

Seagen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Seagen's current stock value. Our valuation model uses many indicators to compare Seagen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seagen competition to find correlations between indicators driving Seagen's intrinsic value. More Info.Seagen Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Seagen's earnings, one of the primary drivers of an investment's value.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

If you are still planning to invest in Seagen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seagen's history and understand the potential risks before investing.